Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/1995
10/24/1995US5460967 Recycle process for the production of low-cost soluble collagen
10/24/1995US5460965 DNA and RNA encoding proteins useful in the regulation of KB-containing genes, and cells containing same
10/24/1995US5460963 Plants transformed with a DNA sequence from Bacillus thuringiensis lethal to Lepidoptera
10/24/1995US5460960 Isolating antibodies produced by a hapten similar to both the reactant and catalyst; modifying these antibodies by binding a converting hapten for the reactant/actual catalyst complex
10/24/1995US5460959 Transduced fibroblasts
10/24/1995US5460956 Method for preparing interferon alpha-2 crystals
10/24/1995US5460955 Fusing a foreign DNA sequence to the fibronectin portion of nucleotide, gene expression in eukaryotic host cell, purifying with chromatography column
10/24/1995US5460954 Production of human proinsulin using a novel vector system
10/24/1995US5460953 Vectors and compounds for expression of glycosylation mutants of human protein C
10/24/1995US5460951 Bone-related carboxypeptidase-like protein and process for its production
10/24/1995US5460950 Expression of PACE in host cells and methods of use thereof
10/24/1995US5460947 Apolipoprotein B-specific monoclonal antibodies produced by two novel hybridomas
10/24/1995US5460945 Device and method for analysis of blood components and identifying inhibitors and promoters of the inflammatory response
10/24/1995US5460831 Targeted transfection nanoparticles
10/24/1995US5460830 Biochemically active agents for chemical catalysis and cell receptor activation
10/24/1995US5460815 Culturing Crandall Feline Kidney cells infected with Dahlberg strain feline infectious peritonitis virus in serum containing growth medium, transferring it to serum-free growth medium, separating viral precursor immunogens, inactivating live virus
10/24/1995US5460811 Mature human fibroblast interferon
10/24/1995US5460810 Method for maintaining gut epithelial cells by treatment with a cytokine such as interleukin 11
10/24/1995US5460785 Direct labeling of antibodies and other protein with metal ions
10/24/1995CA2028903C Promoter for transgenic plants
10/24/1995CA1337406C Regeneration and transformation of cotton
10/24/1995CA1337395C Recombinant herpes simplex gb-gd vaccine
10/21/1995CA2147110A1 Multiple drug resistance gene of aureobasidium pullulans
10/20/1995CA2147344A1 Receptor expression cells and use thereof
10/19/1995WO1995027788A1 Polypeptide derived from variant hepatitis b virus, gene encoding the same, and related dna
10/19/1995WO1995027787A1 Peptide fragment of the respiratory syncytial virus g protein, immunogenic agent, pharmaceutical composition containing same, and preparation method
10/19/1995WO1995027786A1 Pharmaceutical formulations for treating japanese cedar pollen allergy
10/19/1995WO1995027785A1 Behab, a brain hyaluronan-binding protein
10/19/1995WO1995027784A1 Cisplatin resistance gene and uses therefor
10/19/1995WO1995027782A1 Peptide production as fusion protein in transgenic mammal milk
10/19/1995WO1995027780A1 Poxvirus-canine distemper virus (cdv) recombinants and compositions and methods employing the recombinants
10/19/1995WO1995027736A1 Use of agents which block intercellular adhesion molecule/receptor interaction in the treatment of respiratory viral infection
10/19/1995WO1995027735A1 Apoptose inhibitor
10/19/1995WO1995027734A1 A dna molecule encoding a mast cell function-associated antigen (mafa)
10/19/1995WO1995027733A1 Hepatitis c virus core peptide for stimulation of cytotoxic t lymphocytes and diagnosis of hcv exposure
10/19/1995WO1995027732A2 Circularly permuted ligands and circularly permuted chimeric molecules
10/19/1995WO1995027731A1 Compound ge3
10/19/1995WO1995027728A1 Peptides
10/19/1995WO1995027722A1 Interleukin-15
10/19/1995WO1995027512A2 Compositions and methods for gene therapy to treat disease
10/19/1995WO1995027507A1 Immunodeficiency recombinant poxvirus
10/19/1995WO1995027505A1 Cellular immune response-specific antigens and uses therefor
10/19/1995WO1995027504A1 Borrelia burgdorferi bacterin
10/19/1995WO1995027503A1 Antirestenosis protein
10/19/1995WO1995027502A1 Method of treating auto-immune diseases using type one interferons
10/19/1995WO1995027500A1 TREATMENT OF AUTOIMMUNE DISEASE USING ORAL TOLERIZATION AND/OR Th2-ENHANCING CYTOKINES
10/19/1995WO1995027499A1 Treatment of autoimmune disease using oral tolerization and/or type i interferon
10/19/1995WO1995027497A1 Method of combating mammalian neoplasia, and lytic peptides therefor
10/19/1995WO1995027495A2 Treatment of partial growth hormone insensitivity syndrome
10/19/1995WO1995027494A1 DEFECTIVE HERPES AND DEFECTIVE ADENO-ASSOCIATED VIRUS VECTORS WITH p53 FOR THE TREATMENT OF CANCER
10/19/1995WO1995020658A3 Diagnosis and treatment of infections due to streptococci and enterococci
10/19/1995WO1995018855A3 Synthetic antimicrobial peptides
10/19/1995WO1995017904A3 Botulinum toxins for treating various disorders and associated pain
10/19/1995WO1995016044A3 Peptide and protein fusions to thioredoxin, thioredoxin-like molecules, and modified thioredoxin-like molecules
10/19/1995WO1994028145A3 Expression of urokinase plasminogen activator inhibitors
10/19/1995CA2635998A1 Peptide fragment of the respiratory syncytial virus g protein, immunogenic agent, pharmaceutical composition containing same, and preparation method
10/19/1995CA2188675A1 Compositions and methods for gene therapy to treat disease
10/19/1995CA2187550A1 Method of treating auto-immune diseases using type one interferons
10/19/1995CA2187360A1 Use of agents which block intercellular adhesion molecule/receptor interaction in the treatment of respiratory viral infection
10/19/1995CA2187345A1 Treatment of autoimmune disease using oral tolerization and/or th2-enhancing cytokines
10/19/1995CA2187336A1 Pharmaceutical formulations for treating japanese cedar pollen allergy
10/19/1995CA2187299A1 Hepatitis c virus core peptide for stimulation of cytotoxic t lymphocytes and diagnosis of hcv exposure
10/19/1995CA2187173A1 Peptide production as fusion protein in transgenic mammal milk
10/19/1995CA2187031A1 Immunodeficiency recombinant poxvirus
10/19/1995CA2185353A1 Treatment of autoimmune disease using oral tolerization and/or type i interferon
10/19/1995CA2164618A1 Compound ge3
10/19/1995CA2163526A1 Cisplatin resistance gene and uses therefor
10/18/1995EP0677586A1 Recombinant collagenase type II from clostridium histolyticum and its use for the isolation of cells and cellular agglomerations
10/18/1995EP0677584A1 Stable mutants of D-N-alpha-carbamylase
10/18/1995EP0677583A1 Bacillus thuringiensis isolate active against dipteran pests
10/18/1995EP0677582A1 Gene transcipts of MHC class I HLA-G and their applications
10/18/1995EP0677533A2 Antibodies against epitopes with homology to self antigens, methods of preparation and applications thereof
10/18/1995EP0677117A1 Differentiation of htlv-i and htlv-ii using synthetic peptides
10/18/1995EP0677115A1 Tia-1 binding proteins and isolated complementary dna encoding the same
10/18/1995EP0677114A1 Recombinant swinepox virus
10/18/1995EP0677113A1 Viral amplification of recombinant messenger rna in transgenic plants
10/18/1995EP0677109A1 Expression system for producing apolipoprotein ai-m
10/18/1995EP0677108A1 Method for breeding disease resistance into plants
10/18/1995EP0677107A1 Clotting inhibitor made from protostomia saliva.
10/18/1995EP0677106A1 Leukocyte derived growth factors
10/18/1995EP0677105A1 Allergenic proteins and peptides from dog dander and uses therefor
10/18/1995EP0677104A1 Activin receptor-like kinases, proteins having serine threonine kinase domains and their use
10/18/1995EP0677101A1 Peptides representing epitopic sites for bacterial and viral meningitis causing agents and their cns carrier, antibodies thereto, and uses thereof
10/18/1995EP0677063A1 A NEW CLASS OF RPTPases: THEIR STRUCTURAL DOMAINS AND LIGANDS
10/18/1995EP0677062A1 Derivatized calcitonins
10/18/1995EP0677061A1 Polypeptide and anti-hiv agent prepared therefrom
10/18/1995EP0677060A1 Peptide inhibitors of cell adhesion
10/18/1995EP0677053A1 Enhanced yeast expression using regulatory control sequences from yeast sorbitol dehydrogenase gene
10/18/1995EP0676966A1 Antibodies directed against binding-associated epitopes
10/18/1995EP0676965A1 Compounds having reduced immunogenicity and a method of reducing the immunogenicity of compounds
10/18/1995EP0676964A1 Nitrosylation of protein sh groups and amino acid residues as a therapeutic modality
10/18/1995EP0676955A1 Red blood cell surrogate
10/18/1995EP0676954A1 Human immunodeficiency virus decoy
10/18/1995EP0676949A1 Anticaries compositions
10/18/1995EP0620709B1 Process for isolating lactoferrin and lactoperoxidase from milk and milk products
10/18/1995EP0541704A4 Assay, methods and products based on -i(n) k?+ channel expression
10/18/1995EP0515415B1 Novel vaccine and method therefor
10/18/1995CN1110323A Novel polypeptides and DNAS encoding them
10/18/1995CN1110280A Targeted forms of methyltrithio antitumor agents
10/18/1995CN1110279A Method for extracting albumen from animal's blood by precipitating method
1 ... 2576 2577 2578 2579 2580 2581 2582 2583 2584 2585 2586 2587 2588 2589 2590 2591 2592 2593 2594 2595 2596 ... 2916